Yasuhiro Terasaki

2.5k total citations
122 papers, 1.8k citations indexed

About

Yasuhiro Terasaki is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yasuhiro Terasaki has authored 122 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 35 papers in Oncology and 22 papers in Surgery. Recurrent topics in Yasuhiro Terasaki's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (37 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Medical Imaging and Pathology Studies (10 papers). Yasuhiro Terasaki is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (37 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Medical Imaging and Pathology Studies (10 papers). Yasuhiro Terasaki collaborates with scholars based in Japan, United States and United Kingdom. Yasuhiro Terasaki's co-authors include Motohiro Takeya, Mika Terasaki, Yuh Fukuda, Hirokazu Urushiyama, Shinobu Kunugi, Hironori Kobayashi, Akira Shimizu, Koichi Kaikita, William A. Kuziel and Naomi Kuwahara and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Yasuhiro Terasaki

111 papers receiving 1.8k citations

Peers

Yasuhiro Terasaki
Teruaki Oka Japan
William D. Hardie United States
Mostafa Fraig United States
An‐Hang Yang Taiwan
Éric Frisdal France
Takuya Matsumoto Japan
Joon Seon Song South Korea
Chin‐Yuan Tzen Taiwan
Yoshiki Ishii Japan
Guoli Li China
Teruaki Oka Japan
Yasuhiro Terasaki
Citations per year, relative to Yasuhiro Terasaki Yasuhiro Terasaki (= 1×) peers Teruaki Oka

Countries citing papers authored by Yasuhiro Terasaki

Since Specialization
Citations

This map shows the geographic impact of Yasuhiro Terasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Terasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Terasaki more than expected).

Fields of papers citing papers by Yasuhiro Terasaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuhiro Terasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Terasaki. The network helps show where Yasuhiro Terasaki may publish in the future.

Co-authorship network of co-authors of Yasuhiro Terasaki

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuhiro Terasaki. A scholar is included among the top collaborators of Yasuhiro Terasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuhiro Terasaki. Yasuhiro Terasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamio, Koichiro, et al.. (2025). Enfortumab vedotin induced interstitial lung disease: A first case report with pathological evidence from transbronchial lung cryobiopsy. Respiratory Medicine Case Reports. 56. 102237–102237.
2.
Saito, Minako, Naoya Miyashita, Takashi Ishii, et al.. (2025). Sirtuin 3 deficiency exacerbates emphysema and lung inflammation in a murine model of chronic obstructive pulmonary disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 329(2). L200–L213. 1 indexed citations
3.
Chen, Wei‐Li, Etsuko Toda, Kazuhiro Takeuchi, et al.. (2024). Disulfiram treatment suppresses antibody-producing reactions by inhibiting macrophage activation and B cell pyrimidine metabolism. Communications Biology. 7(1). 488–488. 2 indexed citations
4.
Toda, Etsuko, Kazuhiro Takeuchi, Yasuhiro Terasaki, et al.. (2024). Predominant CD8+ cell infiltration and low accumulation of regulatory T cells in immune checkpoint inhibitor‐induced tubulointerstitial nephritis. Pathology International. 74(6). 317–326. 1 indexed citations
5.
Matsumoto, Masaru, Michiko Nakagawa, Yasuhiro Terasaki, et al.. (2024). IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report. Frontiers in Immunology. 15. 1370972–1370972.
6.
Egashira, Ryoko, Mikiko Hashisako, Kiminori Fujimoto, et al.. (2024). Idiopathic dendriform pulmonary ossification as the phenotype of interstitial lung abnormalities: CT–pathologic correlation and prevalence. Japanese Journal of Radiology. 42(9). 993–1002.
7.
Nakamichi, Shinji, Takehiro Tozuka, Rintaro Noro, et al.. (2023). Successful Treatment with Definitive Concurrent Chemoradiotherapy Followed by Durvalumab Maintenance Therapy in a Patient with Tracheal Adenoid Cystic Carcinoma. Internal Medicine. 62(18). 2731–2735. 4 indexed citations
8.
Kamio, Koichiro, Mitsuhiro Takeno, Yasuhiro Terasaki, et al.. (2023). Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review. Therapeutic Advances in Respiratory Disease. 17. 2683737607–2683737607. 2 indexed citations
9.
Miyanaga, Akihiko, Takehiro Tozuka, Yozo Sato, et al.. (2023). Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report. OncoTargets and Therapy. Volume 16. 465–470. 2 indexed citations
10.
Miyakawa, Kazuko, Naoya Miyashita, Masafumi Horie, et al.. (2022). ASCL1 regulates super‐enhancer‐associated miRNAs to define molecular subtypes of small cell lung cancer. Cancer Science. 113(11). 3932–3946. 17 indexed citations
11.
Kawai, Toshiaki, Kuniharu Miyajima, Hiroshi Nakashima, et al.. (2021). Malignant pleural mesothelioma with heterologous elements. Journal of Clinical Pathology. 75(10). 690–695. 2 indexed citations
12.
Nanri, Yasuhiro, Satoshi Nunomura, Yasuhiro Terasaki, et al.. (2019). Cross-Talk between Transforming Growth Factor-β and Periostin Can Be Targeted for Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 62(2). 204–216. 45 indexed citations
13.
Mitani, Akihisa, Yu Mikami, Minoru Horie, et al.. (2019). Epithelial Expression of YAP and TAZ Is Sequentially Required in Lung Development. American Journal of Respiratory Cell and Molecular Biology. 62(2). 256–266. 39 indexed citations
14.
Inoue, Tatsuya, et al.. (2019). Spontaneous pulmonary hematoma with diffuse pulmonary ossification requiring emergency treatment: a case report. SHILAP Revista de lepidopterología. 5(1). 27–27. 3 indexed citations
15.
Terasaki, Yasuhiro, Kinnosuke Yahiro, Gustavo Pacheco–Rodriguez, et al.. (2010). Effects of Prolactin on TSC2 -Null Eker Rat Cells and in Pulmonary Lymphangioleiomyomatosis. American Journal of Respiratory and Critical Care Medicine. 182(4). 531–539. 13 indexed citations
16.
Terasaki, Yasuhiro, Teruo Akuta, Mika Terasaki, et al.. (2006). Guanine Nitration in Idiopathic Pulmonary Fibrosis and Its Implication for Carcinogenesis. American Journal of Respiratory and Critical Care Medicine. 174(6). 665–673. 36 indexed citations
17.
Terasaki, Yasuhiro, et al.. (2004). Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process. International Journal of Experimental Pathology. 85(6). 335–343. 37 indexed citations
18.
Komohara, Yoshihiro, Yasuhiro Terasaki, Koichi Kaikita, et al.. (2004). Clearance of apoptotic cells is not impaired in mouse embryos deficient in class A scavenger receptor types I and II (CD204). Developmental Dynamics. 232(1). 67–74. 19 indexed citations
19.
Okuma, Toshiyuki, Yasuhiro Terasaki, Koichi Kaikita, et al.. (2004). C‐C chemokine receptor 2 (CCR2) deficiency improves bleomycin‐induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage‐derived matrix metalloproteinases. The Journal of Pathology. 204(5). 594–604. 147 indexed citations
20.
KOUFUJI, KIKUO, et al.. (1999). A Study on Metabolic Bone Disease before and after Distal Gastrectomy in Gastric Cancer Patients by Dual X-ray Mineral Absorptometry Measurements and Markers of Bone Metabolism.. The Japanese Journal of Gastroenterological Surgery. 32(12). 2631–2636. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teruaki Oka Breakdown of academic impact, for papers by William D. Hardie Breakdown of academic impact, for papers by Mostafa Fraig Breakdown of academic impact, for papers by An‐Hang Yang Breakdown of academic impact, for papers by Éric Frisdal Breakdown of academic impact, for papers by Takuya Matsumoto Breakdown of academic impact, for papers by Joon Seon Song Breakdown of academic impact, for papers by Chin‐Yuan Tzen Breakdown of academic impact, for papers by Yoshiki Ishii Breakdown of academic impact, for papers by Guoli Li
Rankless by CCL
2026